H
Haruko Matsu
Researcher at Jichi Medical University
Publications - 9
Citations - 191
Haruko Matsu is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Graft-versus-host disease & Transplantation. The author has an hindex of 6, co-authored 9 publications receiving 176 citations.
Papers
More filters
Journal ArticleDOI
Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation
Raine Tatara,Katsutoshi Ozaki,Yuji Kikuchi,Keiko Hatanaka,Iekuni Oh,Akiko Meguro,Haruko Matsu,Kazuya Sato,Keiya Ozawa +8 more
TL;DR: The results suggest that MSC regulate CD4 differentiation through different mechanisms depending on the culture conditions, suggesting that M SC suppress Th17 differentiation at least in part through PGE2 and IDO.
Journal ArticleDOI
Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
Akiko Meguro,Katsutoshi Ozaki,Kazuya Sato,Iekuni Oh,Shin-ichiro Fujiwara,Rie Hosonuma,Miyuki Sasazaki,Yuji Kikuchi,Yuji Hirata,Chihiro Yamamoto,Mitsuyo Uesawa,Hiroyuki Kobayashi,Haruko Matsu,Hiroshi Okabe,Eisuke Uehara,Akinori Nishikawa,Raine Tatara,Kaoru Hatano,Chizuru Yamamoto,Tomohiro Matsuyama,Masaki Toshima,Masuzu Ueda,Ken Ohmine,Takahiro Suzuki,Masaki Mori,Tadashi Nagai,Kazuo Muroi,Keiya Ozawa +27 more
TL;DR: Three-year PFS with R-70%CHOP for patients aged 70 years and older was not significantly worse than that with full-dose R-CHop for younger patients, suggesting that R- 70% CHOP might be a reasonable choice for patients with DLBCL aged 70 year and older, especially for those with comorbidities.
Journal ArticleDOI
IL-21 is critical for GVHD in a mouse model.
Akiko Meguro,Katsutoshi Ozaki,Iekuni Oh,Keiko Hatanaka,Haruko Matsu,Raine Tatara,Kazuya Sato,Warren J. Leonard,Keiya Ozawa +8 more
TL;DR: It is demonstrated that morbidity and mortality of GVHD was significantly reduced after BMT with splenocytes from IL-21R−/− mice compared with those from wild type mice, and that blockade of the IL- 21 signal may represent a novel strategy for the prophylaxis for GV HD.
Journal ArticleDOI
Altered Effector CD4+ T Cell Function in IL-21R−/− CD4+ T Cell-Mediated Graft-Versus-Host Disease
Iekuni Oh,Katsutoshi Ozaki,Akiko Meguro,Keiko Hatanaka,Masanori Kadowaki,Haruko Matsu,Raine Tatara,Kazuya Sato,Yoichiro Iwakura,Susumu Nakae,Katsuko Sudo,Takanori Teshima,Warren J. Leonard,Keiya Ozawa +13 more
TL;DR: It is found that CD25 depletion altered neither the impaired MLR in vitro nor the ameliorated GVHD symptoms in vivo, suggesting that the attenuated GV HD might be caused by an impairment of effector T cell differentiation itself, rather than by an increase in regulatory T cells and suppression of effectors T cells.
Journal ArticleDOI
Lack of IL-21 signal attenuates graft-versus-leukemia effect in the absence of CD8 T-cells.
Akiko Meguro,Katsutoshi Ozaki,Keiko Hatanaka,Iekuni Oh,Katsuko Sudo,Tsukasa Ohmori,Haruko Matsu,Raine Tatara,Kazuhiro Sato,Yoichi Sakata,Susumu Nakae,Warren J. Leonard,Keiya Ozawa +12 more
TL;DR: It is found that Cotransplantation with CD8-depleted splenocytes but not with purified CD8 T-cells resulted in a significant reduction in anti-leukemic effect of IL-21R−/− cells compared with wild-type cells, suggesting the retention of GVL effects in the absence ofIL-21 signaling.